Comparative tumor promotion assessment of e-cigarette and cigarettes using the in vitro Bhas 42 cell transformation assay

Environmental and Molecular Mutagenesis

Volumn 58, Issue 4, 2017, Pages 190-198

  Breheny, Damien ^a   Oke, Oluwatobiloba ^a   Pant, Kamala ^b   Gaça, Marianna ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

^b BioReliance Corporation   (United States)

Author keywords

carcinogenesis; e cigarettes; in vitro; nongenotoxic; risk assessment; tobacco smoke

Indexed keywords

CARCINOGEN; CIGARETTE SMOKE; NICOTINE; TUMOR PROMOTER;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; CARCINOGENICITY; CELL GROWTH ASSAY; CELL TRANSFORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; ELECTRONIC CIGARETTE; FIBROBLAST; GENOTOXICITY ASSAY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICULATE MATTER; RISK ASSESSMENT; TOBACCO; TUMOR PROMOTION; ADVERSE EFFECTS; ANIMAL; NEOPLASM; PATHOLOGY;

ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; ELECTRONIC CIGARETTES; IN VITRO TECHNIQUES; MICE; NEOPLASMS;

EID: 85018281317     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.22091     Document Type: Article

References (37)

1. Aufderheide M, Gressmann H. 2008. Mutagenicity of native cigarette mainstream smoke and its gas/vapour phase by use of different tester strains and cigarettes in a modified Ames assay. Mutat. Res 656:82–87.
2. Berwald Y, Sachs L. 1963. In vitro cell transformation with chemical carcinogens. Nature 200:1182–1184.
3. Breheny D, Zhang H, Massey ED. 2005. Application of a two-stage Syrian hamster embryo cell transformation assay to cigarette smoke particulate matter. Mutat Res 572:45–57.
4. Breheny D, Oke O, Camacho OM, Pant K, Bruce S, LaForce MK, Celestin N. 2015. Application of the Bhas 42 cell transformation assay to the assessment of novel tobacco products. Toxicol Lett 238, 2(Suppl):S242–S243
5. Cancer Research UK. 2016a. UK cancer incidence statistics. Cancer Research UK Website (accessed November 22, 2016).
6. Cancer Research UK. 2016b. UK cancer mortality statistics for common cancers. Cancer Research UK Website (accessed November 22, 2016).
7. Coggins CR. 2002. A minireview of chronic animal inhalation studies with mainstream cigarette smoke. Inhal Toxicol 14:991–1002.
8. CORESTA. 2015. CORESTA Recommended Method No. 81. Routine analytical machine for e-cigarette aerosol generation and collection—Definitions and standard conditions. CRM No 81, 2015. https://www.coresta.org/sites/default/files/technical_documents/main/CRM_81.pdf (accessed December 3, 2016).
9. DeMarini D, Gudi R, Szkudlinska A, Rao M, Reico L, Kehl M, Kirby P, Polzin G, Richter P. 2008. Genotoxicity of 10 cigarette smoke condensates in four test systems: Comparisons between assays and condensates. Mutat Res 650:15–29.
10. Doll R, Peto R. 1981. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66:1191–1308.
11. EURL ECVAM. 2013. EU Reference Laboratory for Alternatives to Animal Testing. EURL ECVAM recommendation on the cell transformation assay based on the Bhas 42 cell line. JRC Scientific and Policy Reports 2013. https://eurl-ecvam.jrc.ec.europa.eu/eurl-ecvam-recommendations/files-bhas/EURL_ECVAM_Recommendation_Bhas-CTA_2013.pdf (accessed December 3, 2016)
12. Farsalinos KE, Gillman IG, Hecht SS, Polosa R, Thornburg, J. 2016. Analytical Assessment of e-Cigarettes: From Contents to Chemical and Particle Exposure Profiles. New York: Elsevier.
13. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. 2013. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer.
14. Han SG, Pant K, Bruce SW, Gairola CG. 2016. Bhas 42 cell transformation activity of cigarette smoke condensate is modulated by selenium and arsenic. Environ Mol Mutagen 57:220–228.
15. Health Canada. 1999. Health Canada Official Method T-115. Determination of “Tar”, Nicotine and Carbon Monoxide in Mainstream Tobacco Smoke. Department of Health, December 31, 1999.
16. Hecht SS. 2005. Carcinogenicity studies of inhaled cigarette smoke in laboratory animals: Old and new. Carcinogenesis 26:1488–1492.
17. International Organization for Standardization 1999. Tobacco and tobacco products—Atmosphere for conditioning and testing. ISO 3402:1999. http://www.iso.org/iso/catalogue_detail.htm?csnumber=28324 (accessed December 3, 2016).
18. International Organization for Standardization 2000. Cigarettes—determination of total and nicotine-free dry particulate matter using a routine analytical smoking machine. ISO 4387:2000. http://www.iso.org/iso/catalogue_detail.htm?csnumber=28323 (accessed December 3, 2016).
19. Lowe F, Fearon IM, Camacho OM, Minet E, Murphy J. 2015. A framework for the assessment of reduced risk tobacco and nicotine products. Recent Adv Tob Sci 41:51–82.
20. Margham J, McAdam K, Forster M, Liu C, Wright C, Mariner D, Proctor C. 2016. Chemical composition of an e-cigarette aerosol: A quantitative comparison with cigarette smoke. Chem Res Toxicol 29:1662–1678.
21. Meckley DR, Hayes JR, Van Kampen KR, Ayres PH, Mosberg AT, Swauger JE. 2004. Comparative study of smoke condensates from 1R4F cigarettes that burn tobacco versus ECLIPSE cigarettes that primarily heat tobacco in the SENCAR mouse dermal tumor promotion assay. Food Chem Toxicol 42:851–863.
22. Ohmori K, Sasaki K, Asada S, Tanaka N, Umeda M. 2004. An assay method for the prediction of tumor promoting potential of chemicals by the use of Bhas 42 cells. Mutat Res 557:191–202.
23. Ohmori K, Umeda M, Tanaka N, Takagi H, Yoshimura I, Sasaki K, Asasda S, Sakai A, Araki H, Asakura M, et al. 2005. Inter-laboratory collaborative study of cell transformation assay for tumor promoters using Bhas 42 cells by non-genotoxic carcinogen study group in Japan. Altern Lab Anim 33:1–21.
24. Organisation for Economic and Cooperative Development. 2016. Guidance Document on the in vitro Bhas 42 cell transformation assay. Series on Testing and Assessment. No. 231. Paris. https://www.oecd.org/env/ehs/testing/ENV_JM_MONO(2016)1.pdf (accessed December 3, 2016).
25. Peto J. 2001. Cancer epidemiology in the last century and the next decade. Nature 411:390–395.
26. Public Health England (2015). E-cigarettes: An Evidence Update. London: Public Health England.
27. Rodgman A, Perfetti TA. 2013. The Chemical Components of Tobacco and Tobacco Smoke, 2nd ed. Boca Raton, FL: CRC Press.
28. Roe FJ, Salaman MH, Cohen J. 1959. Incomplete carcinogens in cigarette smoke condensate: Tumour-promotion by a phenolic fraction. Br J Cancer 13:623–633.
29. Royal College of Physicians (2016). Nicotine without smoke: Tobacco harm reduction. London: RCP.
30. Sasaki K, Mizusawa H, Ishidate M, Tanaka N. 1990. Establishment of a highly reproducible transformation assay of a ras-transfected BALB/3T3 clone by treatment with promoters. Basic Life Sci 52:411–416.
31. Smith CJ, Perfetti TA, Garg R, Hansch C. 2006. Utility of the mouse dermal promotion assay in comparing the tumorigenic potential of cigarette mainstream smoke. Food Chem Toxicol 44:1699–1706.
32. Taylor M, Carr T, Oke O, Jaunky J, Breheny D, Lowe F, Gaça M. 2016. E-cigarette aerosols induce lower oxidative stress in vitro when compared to tobacco smoke. Toxicol Mech Methods 26:465–476.
33. Thorne D, Kilford J, Hollings M, Dalrymple A, Ballantyne M, Meredith C, Dillon D. 2015. The mutagenic assessment of mainstream cigarette smoke using the Ames assay: A multi-strain approach. Mutat Res 782:9–17.
34. Thorne D, Crooks I, Hollings M, Seymour A, Meredith C, Gaça M. 2016. The mutagenic assessment of electronic-cigarettes and tobacco smoke using the Ames assay in strains TA98 and TA100. Mutat Res 812:29–38.
35. Thorne D, Larard S, Baxter A, Meredith C, Gaça M. 2017. The in vitro assessment of e-cigarette aerosol DNA induced damage using the µ-H2AX assay. Toxicol Lett 265:170–178.
36. Walaszek Z, Hanausek M, Slaga TJ. 2007. The role of skin painting in predicting lung cancer. Int J Toxicol 26:345–351.
37. Weisensee D, Poth A, Roemer E, Conroy LL, Schlage WK. 2013. Cigarette smoke-induced morphological transformation of Bhas 42 cells in vitro. Altern Lab Anim 41:181–189.